# SPRO (Spero Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Spero Therapeutics, Inc. reported $41.55M in revenue and a net loss of $29.51M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year), with a -67.3% operating margin.

- Canonical: https://convexityos.com/fundamentals/SPRO
- Markdown: https://convexityos.com/fundamentals/SPRO.md
- SEC CIK: 0001701108
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:52 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001701108&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $41.55M | -100.0% YoY |
| Operating Income | TTM | -$27.97M | -67.3% margin |
| Net Income | TTM | -$29.51M | -71.0% net margin |
| Diluted EPS | TTM | -$0.51 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $107.9M | Total debt: $1.59M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $66.80M | $47.98M | $103.8M | $53.51M | $18.26M | $9.33M | $18.15M | $3.97M | $1.98M | $335K |
| Research & Development | $38.47M | $96.76M | $51.44M | $47.59M | $64.53M | $67.00M | $65.78M | $33.88M | $32.87M | $26.33M |
| Total Operating Expenses | $60.49M | $121.3M | $82.30M | $95.71M | $106.2M | $88.44M | $81.36M | $46.77M | $43.71M | $33.56M |
| **Operating Income** | $6.31M | -$73.36M | $21.48M | -$42.20M | -$87.97M | -$79.11M | -$63.22M | -$42.81M | -$41.73M | -$33.22M |
| **EBITDA** | $6.31M | -$73.36M | $21.85M | -$41.33M | -$87.33M | -$78.35M | -$62.47M | -$42.40M | -$41.37M | -$32.94M |
| Interest Income | $2.51M | $4.74M | $3.94M | $1.11M | $346K | $401K | $1.33M | $1.10M | -- | -- |
| Income Before Tax | $8.83M | -$68.57M | $25.40M | -$46.41M | -$89.76M | -$78.28M | -$60.92M | -$41.66M | -$39.89M | -$32.64M |
| Income Tax Expense | $261K | $0 | $2.60M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | $8.57M | -$68.57M | $22.81M | $46.41M | -$89.80M | -$78.30M | -$60.90M | -$41.70M | -$38.74M | -$25.49M |
| Basic EPS | $0.15 | -$1.27 | $0.43 | -$1.23 | -$2.91 | -$3.52 | -$3.35 | -$2.60 | -$17.82 | -$95.87 |
| **Diluted EPS** | $0.15 | -$1.27 | $0.43 | -$1.23 | -$2.91 | -$3.52 | -$3.35 | -$2.60 | -$17.82 | -$95.87 |
| Basic Shares Outstanding | 56.0M | 54.0M | 52.7M | 37.6M | 30.9M | 22.4M | 18.2M | 16.0M | 2.6M | 312.2K |
| Diluted Shares Outstanding | 59.0M | 54.0M | 53.0M | 37.6M | 30.9M | 22.4M | 18.2M | 16.0M | 2.6M | 312.2K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $258K | $41.30M | $5.44M | $14.19M | $5.87M | $15.04M |
| Research & Development | $3.20M | $3.43M | $2.91M | $5.59M | $8.60M | $10.67M | $13.61M | $28.84M |
| Total Operating Expenses | $41.91M | $9.93M | $7.80M | $9.89M | $13.36M | $16.63M | $20.61M | $36.77M |
| **Operating Income** | -$41.91M | -$9.93M | -$7.54M | $31.41M | -$7.92M | -$2.44M | -$14.73M | -$21.73M |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -- | -$21.73M |
| Interest Income | $912K | $377K | $336K | $376K | $532K | $740K | $864K | $1.03M |
| Income Tax Expense | -- | -- | -- | -- | $0 | -- | -- | -- |
| **Net Income** | -$44.28M | -$9.55M | -$7.20M | $31.52M | -$7.38M | -$1.70M | -$13.87M | -$20.89M |
| Basic EPS | -$0.76 | -$0.16 | -$0.13 | -- | -$0.13 | -$0.03 | -$0.25 | -- |
| **Diluted EPS** | -$0.76 | -$0.16 | -$0.13 | -- | -$0.13 | -$0.03 | -$0.25 | -- |
| Basic Shares Outstanding | 58.2M | 58.0M | 57.3M | -- | 56.3M | 56.0M | 55.4M | -- |
| Diluted Shares Outstanding | 58.2M | 58.0M | 57.3M | -- | 56.3M | 56.0M | 55.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $40.27M | $52.89M | $76.33M | $109.1M | $112.6M | $85.21M | $29.73M | $34.08M | $87.29M | $10.31M |
| Short-Term Investments | -- | -- | -- | $0 | $33.82M | $41.70M | $52.31M | $81.36M | -- | -- |
| **Cash & Short-Term Investments** | $40.27M | $52.89M | $76.33M | $109.1M | $146.4M | $126.9M | $82.05M | $115.4M | $87.29M | $10.31M |
| Other Current Assets | $28K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Current Assets** | $67.29M | $107.3M | $131.2M | $113.6M | $157.9M | $139.1M | $95.41M | $124.2M | $92.06M | $11.87M |
| Property, Plant & Equipment, Net | -- | $0 | $2.0K | $368K | $1.03M | $1.67M | $2.27M | $2.89M | $1.16M | $1.50M |
| Other Non-Current Assets | $153K | $153K | $435K | $5.74M | $5.64M | $5.21M | $3.52M | $1.66M | -- | -- |
| **Total Non-Current Assets** | $1.63M | $3.27M | $51.18M | $11.23M | $13.20M | $14.31M | $10.69M | $4.79M | $1.42M | $1.90M |
| **Total Assets** | $68.92M | $110.5M | $182.4M | $124.8M | $171.1M | $153.5M | $106.1M | $129.0M | $93.48M | $13.77M |
| Accounts Payable | $693K | $7.31M | $1.38M | $617K | $1.10M | $1.16M | $4.15M | $3.60M | $3.47M | $1.14M |
| Deferred Revenue (Current) | $0 | $368K | $2.13M | $4.15M | $1.86M | $0 | -- | -- | -- | -- |
| **Total Current Liabilities** | $8.87M | $49.07M | $37.15M | $21.65M | $18.67M | $14.34M | $26.66M | $12.32M | $8.16M | $6.92M |
| Deferred Revenue (Non-Current) | $0 | $12.22M | $10.82M | $9.74M | $8.79M | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $1.03M | $15.35M | $38.34M | $27.22M | $64.11M | $7.07M | $4.87M | $833K | $365K | $493K |
| **Total Liabilities** | $9.90M | $64.42M | $75.50M | $48.87M | $82.78M | $21.41M | $31.53M | $13.15M | $8.52M | $7.41M |
| **Total Debt (incl. Leases)** | $2.90M | $4.30M | $5.54M | $6.65M | $7.33M | $7.84M | $5.54M | -- | -- | -- |
| Common Stock | $56K | $55K | $53K | $52K | $32K | $29K | $19K | $17K | $14K | $0 |
| Retained Earnings | -$451.1M | -$459.6M | -$391.1M | -$413.9M | -$367.5M | -$277.7M | -$199.4M | -$138.5M | -$96.84M | -$45.44M |
| Accumulated Other Comp. Income | -- | -- | $0 | $0 | -$2.0K | -$7.0K | $16K | -$28K | -- | -- |
| **Total Stockholders' Equity** | $59.02M | $46.12M | $106.9M | $75.93M | $88.29M | $132.0M | $74.57M | $115.5M | $84.60M | -$45.44M |
| Total Equity | $59.02M | $46.12M | $106.9M | $75.93M | $88.29M | $132.0M | $74.57M | $115.9M | $84.96M | -$49.25M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $107.9M | $50.77M | $56.13M | $40.27M | $48.62M | $31.19M | $48.89M | $52.89M |
| **Cash & Short-Term Investments** | $107.9M | $50.77M | $56.13M | $40.27M | $48.62M | $31.19M | $48.89M | $52.89M |
| Other Current Assets | $12K | $25K | -- | $28K | -- | -- | -- | -- |
| **Total Current Assets** | $109.2M | $51.58M | $57.61M | $67.29M | $52.32M | $59.40M | $74.71M | $107.3M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | -- | $0 |
| Other Non-Current Assets | $0 | $153K | $153K | $153K | $153K | $153K | $153K | $153K |
| **Total Non-Current Assets** | $798K | $1.18M | $1.41M | $1.63M | $1.85M | $2.72M | $3.00M | $3.27M |
| **Total Assets** | $110.0M | $52.77M | $59.02M | $68.92M | $54.17M | $62.12M | $77.71M | $110.5M |
| Accounts Payable | $411K | $155K | $217K | $693K | $1.40M | $780K | $1.76M | $7.31M |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $0 | $0 | $0 | $368K |
| **Total Current Liabilities** | $56.96M | $8.43M | $5.49M | $8.87M | $13.65M | $14.95M | $29.16M | $49.07M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $12.57M | $12.57M | $12.57M | $12.22M |
| **Total Non-Current Liabilities** | $52.28M | $134K | $598K | $1.03M | $14.03M | $14.35M | $14.74M | $15.35M |
| **Total Liabilities** | $109.2M | $8.56M | $6.09M | $9.90M | $27.68M | $29.29M | $43.90M | $64.42M |
| **Total Debt (incl. Leases)** | $1.59M | $2.04M | $2.47M | $2.90M | $3.35M | $3.62M | $3.96M | $4.30M |
| Common Stock | $58K | $58K | $58K | $56K | $56K | $56K | $56K | $55K |
| Retained Earnings | -$512.1M | -$467.8M | -$458.3M | -$451.1M | -$482.6M | -$475.2M | -$473.5M | -$459.6M |
| **Total Stockholders' Equity** | $781K | $44.20M | $52.93M | $59.02M | $26.49M | $32.83M | $33.81M | $46.12M |
| Total Equity | $781K | $44.20M | $52.93M | $59.02M | $26.49M | $32.83M | $33.81M | $46.12M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $8.57M | -$68.57M | $22.81M | -$46.41M | -$89.76M | -$78.28M | -$60.92M | -$41.66M | -$39.89M | -$32.64M |
| Depreciation & Amortization | $0 | $2.0K | $367K | $869K | $646K | $761K | $750K | $409K | $363K | $279K |
| Stock-Based Compensation | $4.33M | $7.79M | $7.93M | $9.12M | $9.43M | $4.89M | $3.78M | $2.75M | $1.43M | $180K |
| Change in Payables | -$6.61M | $5.93M | $761K | -$484K | -$53K | -$2.98M | $564K | $84K | $2.35M | -$644K |
| **Operating Cash Flow** | -$12.62M | -$23.44M | -$32.99M | -$7.73M | -$64.35M | -$85.87M | -$50.02M | -$39.62M | -$39.11M | -$28.96M |
| Capital Expenditure | -- | -- | -- | -- | -- | -$157K | -$314K | -$2.44M | -$27K | -$830K |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -$86.03M | -$50.33M | -$42.06M | -$39.14M | -$29.79M |
| Purchases of Investments | -- | -- | $0 | -$26.97M | -$43.91M | -$45.72M | -$88.99M | -$130.2M | -- | -- |
| **Investing Cash Flow** | -- | -- | $0 | $33.81M | $7.67M | $10.47M | $29.53M | -$83.16M | -$27K | -$830K |
| Common Stock Issued | -- | $0 | $221K | -- | $7.83M | $13.17M | $15.79M | -- | -- | -- |
| **Financing Cash Flow** | -- | $0 | $221K | -$29.55M | $84.05M | $130.9M | $16.14M | $69.52M | $116.1M | $34.41M |
| **Net Change in Cash** | -$12.62M | -$23.44M | -$32.77M | -$3.48M | $27.38M | $55.48M | -$4.35M | -$53.26M | $76.97M | $4.62M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$44.28M | -$9.55M | -$7.20M | $31.52M | -$7.38M | -$1.70M | -$13.87M | -$20.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | $0 |
| Stock-Based Compensation | $855K | $822K | $1.11M | $1.01M | $1.05M | $714K | $1.56M | $1.50M |
| Change in Payables | $256K | -$62K | -$476K | -$702K | $615K | -$985K | -$5.54M | $1.22M |
| **Operating Cash Flow** | -$42.61M | -$5.36M | $15.86M | -$8.35M | $17.42M | -$17.69M | -$4.00M | -$23.40M |
| **Net Change in Cash** | $57.15M | -$5.36M | $15.86M | -$8.35M | $17.42M | -$17.69M | -$4.00M | -$23.40M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 9.5% | -152.9% | 20.7% | -78.9% | -481.9% | -847.9% | -348.4% | -1079.3% | -2108.6% | -9916.7% |
| **Net Profit Margin** | 12.8% | -142.9% | 22.0% | 86.7% | -491.9% | -839.2% | -335.6% | -1051.4% | -1957.7% | -7609.3% |
| Return on Equity (ROE) | 14.5% | -148.7% | 21.3% | 61.1% | -101.7% | -59.3% | -81.7% | -36.1% | -45.8% | -- |
| Return on Assets (ROA) | 12.4% | -62.0% | 12.5% | 37.2% | -52.5% | -51.0% | -57.4% | -32.3% | -41.4% | -185.1% |
| Current Ratio | 7.59x | 2.19x | 3.53x | 5.25x | 8.46x | 9.70x | 3.58x | 10.08x | 11.29x | 1.72x |
| Quick Ratio | 4.54x | 1.08x | 2.05x | 5.04x | 7.84x | 8.85x | 3.08x | 9.37x | 10.70x | 1.49x |
| Debt to Equity | 0.05x | 0.09x | 0.05x | 0.09x | 0.08x | 0.06x | 0.07x | -- | -- | -- |
| **Revenue Growth (YoY)** | +39.2% | -53.8% | +94.0% | +193.1% | +95.7% | -48.6% | +357.6% | +100.4% | +490.7% | -- |
| Operating Income Growth (YoY) | -- | -441.5% | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -400.6% | -50.9% | -- | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -395.3% | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | +186.1% | -11.1% | +694.5% | +86.1% | -44.9% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -67.3% | 12.8% | 22.1% | 9.5% | -115.5% | -118.4% | -166.2% | -152.9% |
| **Net Profit Margin** | -71.0% | 15.7% | 24.9% | 12.8% | -108.1% | -110.3% | -156.5% | -142.9% |
| Return on Equity (ROE) | -3778.9% | 16.7% | 28.8% | 14.5% | -165.5% | -163.3% | -206.3% | -148.7% |
| Return on Assets (ROA) | -26.8% | 14.0% | 25.8% | 12.4% | -80.9% | -86.3% | -89.8% | -62.0% |
| Current Ratio | 1.92x | 6.12x | 10.50x | 7.59x | 3.83x | 3.97x | 2.56x | 2.19x |
| Quick Ratio | 1.89x | 6.02x | 10.23x | 4.54x | 3.56x | 2.09x | 1.68x | 1.08x |
| Debt to Equity | 2.04x | 0.05x | 0.05x | 0.05x | 0.13x | 0.11x | 0.12x | 0.09x |
| **Revenue Growth (YoY)** | -100.0% | -100.0% | -95.6% | +174.5% | -59.6% | +39.1% | -36.6% | -79.5% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -143.0% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -140.8% |
| Operating Cash Flow Growth (YoY) | -344.6% | -- | -- | -- | +36.5% | -- | -167.4% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
